(Q47757836)

5 February 2018

title

Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways (English)

1 reference

5 February 2018

author name string

Latha Satish

1

1 reference

5 February 2018

Mary Babu

2

1 reference

5 February 2018

Kien T Tran

3

1 reference

5 February 2018

Patricia A Hebda

4

1 reference

5 February 2018

Alan Wells

5

1 reference

5 February 2018

publication date

1 March 2004

1 reference

5 February 2018

Wound Repair and Regeneration

published in

1 reference

5 February 2018

volume

12

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

183-192

1 reference

5 February 2018

Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Excessive scarring as a consequence of healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Gene expression of tenascin is altered in normal scars and keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Increased expression of tenascin C by keloids in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Keloid fibroblasts exhibit an altered response to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Engineering epidermal growth factor for enhanced mitogenic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Immunolocalization of Epidermal Growth Factor Receptors in Normal Developing Human Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Epidermal and dermal effects of epidermal growth factor during wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Growth-factor-dependent mitogenesis requires two distinct phases of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

Growth factors in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2004.012111.X

10.1111/J.1067-1927.2004.012111.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018